Qualigen Therapeutics Stock Technical Analysis
| QLGN Stock | USD 4.28 0.22 4.89% |
As of the 12th of December 2024, Qualigen Therapeutics holds the Variance of 44.64, risk adjusted performance of (0.06), and Coefficient Of Variation of (1,044). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Qualigen Therapeutics, as well as the relationship between them.
Qualigen Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Qualigen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to QualigenQualigen |
Qualigen Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 40.0 | Strong Buy | 1 | Odds |
Most Qualigen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Qualigen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Qualigen Therapeutics, talking to its executives and customers, or listening to Qualigen conference calls.
Qualigen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Qualigen Therapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Qualigen Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Qualigen Therapeutics Trend Analysis
Use this graph to draw trend lines for Qualigen Therapeutics. You can use it to identify possible trend reversals for Qualigen Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Qualigen Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Qualigen Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Qualigen Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.1 , which may suggest that Qualigen Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 366.92, which is the sum of squared deviations for the predicted Qualigen Therapeutics price change compared to its average price change.About Qualigen Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Qualigen Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Qualigen Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Qualigen Therapeutics price pattern first instead of the macroeconomic environment surrounding Qualigen Therapeutics. By analyzing Qualigen Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Qualigen Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Qualigen Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 4.89 | 6.94 | 2.34 | 2.23 | Days Of Inventory On Hand | 88.95 | 134.56 | 121.11 | 127.16 |
Qualigen Therapeutics December 12, 2024 Technical Indicators
Most technical analysis of Qualigen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Qualigen from various momentum indicators to cycle indicators. When you analyze Qualigen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 4.05 | |||
| Coefficient Of Variation | (1,044) | |||
| Standard Deviation | 6.68 | |||
| Variance | 44.64 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.90) | |||
| Total Risk Alpha | (1.71) | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 47.03 | |||
| Value At Risk | (8.39) | |||
| Potential Upside | 9.21 | |||
| Skewness | (2.45) | |||
| Kurtosis | 14.22 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.6 K | Revenue Per Share 1.034 | Quarterly Revenue Growth 0.137 | Return On Assets (0.75) | Return On Equity (8.42) |
The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.